Find your missing element at CPHI Milan 2024

Discover a different kind of CDMO in Italy

 

Book a meeting with us at CPHI Milan to learn how our elements of partnership power pharmaceutical success.

October 8-10, 2024

In-person

Fiera Milano, Italy

Booth: 7B18

We look forward to meeting you in Italy

CPHI is pharma’s biggest event of the year — an opportunity to uncover innovation at the source, learn about emerging trends, and connect with industry experts.

The event is widely referred to as being at the heart of pharma, and we believe that as an industry-leading, integrated CDMO/CRO, Thermo Fisher Scientific is at the heart of CPHI.

Schedule a meeting to discover what makes us a different kind of CDMO/CRO and how we can support your drug research, development, and manufacturing journey.

You can’t miss this: Thought leadership session

Jennifer Cannon - Thermo Fisher Scientific - CPHI Milan


Be sure to attend Thermo Fisher Scientific’s thought leadership session at CPHI Milan: “Maximizing outsourcing and manufacturing success through strategic CDMO and CRO partnerships.

Date: Wednesday, October 9, 2024
Time: 13:45 – 14:10 CEST
Location: CPHI Milan, Hall 5

Led by Jennifer Cannon, Ph.D., President of Commercial Operations at Thermo Fisher Scientific, this session will explore the dynamic evolution of CDMOs within the pharmaceutical industry.

Learn more below:

In a landscape marked by breakthrough treatments and demands for speed and innovation, CDMOs have shifted from service providers to strategic partners. They now play a critical role in introducing new therapies, offering innovative service models and customized solutions amid challenges like supply chain disruptions and regulatory shifts.

Attendees will gain insight into the evolution of CDMOs into essential collaborators for biotechnology and pharmaceutical companies. It will explore how these partnerships streamline the path to Investigational New Drug (IND) submission, optimize supply chains, mitigate risks, and accelerate the development and commercialization of new therapies.


Panel discussion: Navigating industry shifts in CDMO-pharma relations: Trends and Implications

Dr. Hrissi Samartzidou, VP of Global Marketing at Thermo Fisher Scientific


Dr. Hrissi Samartzidou, VP of Commercial Strategy, Product, and Market Development at Thermo Fisher Scientific, will join in this panel discussion focusing on recent developments in the pharmaceutical industry, and how they’re driving significant transformation in the CDMO and CRO space.

Date: Tuesday, October 8, 2024
Time: 11:35 – 12:30 CEST
Location: CPHI Milan, Hall 5

Key discussion points will include:

  • How CDMOs are broadening partnerships and driving innovation through integrated services, technology, and expertise
  • Reviewing evolving CDMO-pharma relationships and their role in helping to efficiently bring new therapies to market
  • How CDMOs are adapting to meet evolving regulatory requirements and ensure quality and compliance globally
  • Predicting the next phase of evolution and how CDMOs can continue providing value in a rapidly changing industry

Fireside chat: Navigating outsourcing partnerships for start-ups

Kelly Howard, Vice President, Commercial Operations, VVS Global and Advanced Therapies


Kelly Howard, Vice President, Commercial Operations, VVS Global and Advanced Therapies, will join this fireside chat on navigating outsourcing partnerships for start-ups, exploring effective strategies and best practices for collaborating with external partners to accelerate growth and drive innovation.

Date: Tuesday, October 8, 2024
Time: 13:15 – 13:30 CEST
Location: CPHI Milan, Hall 5

Key discussion points will include:

  • Partnership considerations: Assessing their experience, technical expertise, and cutting-edge technology to effectively support start-up initiatives from development to market
  • Strategies for innovation and scalability: Ensuring smooth product transitions through development stages while addressing supply chain challenges for timely and reliable delivery
  • Approaches to managing the high cost of goods in the cell and gene therapy sector: Exploring innovative funding solutions to manage cash flow and drive down expenses

Tour our state-of-the-art site in Monza

While you’re in Italy, visit our site in Monza, which specializes in the manufacturing and fill-finish of prefilled syringes, cartridges, liquid and lyophilized products, and mRNA.

We’re currently scheduling tours for Monday, October 7 from 12:00-16:00 CEST. We will provide transportation from the Monza train station to our state-of-the-art facility.

Leverage this opportunity to explore our end-to-end CDMO/CRO capabilities and connect with our local experts who help drug developers accelerate their time to market.

 

Find your missing element with Thermo Fisher Scientific

Insights and resources

Discover a different kind of CDMO at CPHI

 

Continuing education for the pharma industry 

 

Follow us on social for event updates